Massachusetts · 194th Legislature (2025-2026) · Bill
H 2372: An Act relative to collaborative drug therapy management optimization
In committee Official data
- Introduced
- In committee
- Passed one chamber
- Passed both chambers
- Enacted
Last official action: ·Record last updated:
Plain-language summary
H 2372 is a bill introduced in the Massachusetts House on February 27, 2025. According to its official title, it concerns: An Act relative to collaborative drug therapy management optimization. Primary sponsor: Christine Barber (Democratic). It lists 1 additional sponsor. Most recent recorded action (April 15, 2026): Committee recommended bill ought to pass and referred to the committee on House Ways and Means.
Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written
Official summary
Abstract published by the legislature (via Open States). Text as published by the legislature; reproduced verbatim.
By Representative Barber of Somerville, a petition (accompanied by bill, House, No. 2372) of Christine P. Barber and Patrick Joseph Kearney relative to collaborative drug therapy management optimization. Public Health.
Sponsors
Sponsors by party (alphabetical): Democratic 2
| Name | Role | Party | Chamber | District |
|---|---|---|---|---|
| Christine Barber | Primary sponsor | Democratic | House | 34th Middlesex |
| Patrick Kearney | Co-sponsor | Democratic | House | 4th Plymouth |
“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.
Recent official actions
- Committee recommended bill ought to pass and referred to the committee on House Ways and Means
- Reporting date extended to Monday, June 15, 2026
- Reporting date extended to Wednesday, March 18, 2026
- Reported favorably by committee and referred to the committee on Health Care Financing
- Hearing scheduled for 06/11/2025 from 01:00 PM-05:00 PM in A-1
- Senate concurred
- Referred to the committee on Public Health